sinc
outbreak
press
need
develop
prognost
tool
easi
clinician
use
recent
lancet
public
show
cohort
patient
age
sofa
score
ddimer
measur
associ
mortal
public
involv
prognost
factor
model
identifi
date
cohort
patient
two
hospit
sofa
score
low
major
patient
admiss
relev
ddimer
could
verifi
includ
routin
laboratori
test
studi
establish
multivari
clinic
predict
model
use
develop
cohort
patient
one
hospit
backward
select
four
variabl
includ
age
lymphocyt
count
lactat
dehydrogenas
remain
model
predict
mortal
valid
intern
extern
cohort
patient
differ
hospit
discrimin
model
excel
intern
extern
valid
calibr
plot
show
excel
agreement
predict
observ
probabl
mortal
recalibr
model
account
underli
differ
risk
profil
dataset
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
background
pandem
develop
rapidli
abil
stratifi
vulner
patient
vital
howev
routin
use
sever
score
system
often
low
diagnosi
even
nonsurvivor
therefor
clinic
predict
model
mortal
urgent
requir
develop
intern
valid
multivari
logist
regress
model
predict
inpati
mortal
posit
patient
use
data
collect
retrospect
tongji
hospit
wuhan
patient
extern
valid
conduct
use
retrospect
cohort
jinyintan
hospit
wuhan
patient
nine
variabl
commonli
measur
acut
set
consid
model
develop
includ
age
biomark
comorbid
backward
stepwis
select
bootstrap
resampl
use
model
develop
intern
valid
assess
discrimin
via
c
statist
calibr
use
calibrationinthelarg
calibr
slope
plot
demonstr
model
abl
make
reliabl
predict
patient
differ
hospit
addit
variabl
agre
patholog
mechan
model
easi
use
type
clinic
set
extern
valid
differ
countri
model
enabl
better
risk
stratif
target
manag
patient
nomogram
model
base
readili
avail
paramet
help
clinician
stratifi
patient
diagnosi
use
limit
healthcar
resourc
effect
improv
patient
outcom
sinc
outbreak
coronaviru
diseas
decemb
china
confirm
case
develop
sever
approxim
requir
intens
care
although
number
daili
case
significantli
reduc
china
intens
control
procedur
number
rest
world
continu
increas
death
report
estim
mortal
rate
much
lower
sever
acut
respiratori
syndrom
sar
lifethreaten
stratif
patient
becom
increasingli
import
larg
popul
expect
infect
global
death
morbid
infect
primarili
due
respiratori
failur
although
peopl
die
multipl
organ
failur
mof
chronic
comorbid
therefor
reduc
oxygen
satur
major
indic
diseas
sever
howev
symptom
onset
rel
mild
substanti
proport
patient
obviou
symptom
prior
develop
respiratori
failur
clinic
difficult
stratifi
patient
may
develop
lethal
respiratori
failur
develop
sinc
earli
identif
effect
treatment
reduc
mortal
morbid
well
reliev
resourc
shortag
urgent
need
effect
predict
model
identifi
patient
like
develop
respiratori
failur
poor
outcom
robust
highli
discriminatori
valid
clinic
prognosi
model
requir
stratif
patient
current
report
propos
reliabl
predict
model
construct
use
transpar
report
multivari
predict
model
individu
prognosi
diagnosi
tripod
guidanc
intern
extern
valid
one
report
base
cohort
covid
patient
earli
stage
pandem
show
age
sequenti
organ
failur
assess
sofa
score
ddimer
independ
risk
factor
mortal
howev
ddimer
routin
avail
clinic
measur
sofa
rel
low
patient
admiss
aforement
report
patient
late
stage
transfer
studi
hospit
might
explain
differ
sofa
score
studi
aim
employ
routin
wide
avail
clinic
test
data
predict
mortal
hospitalis
patient
use
multivari
regress
analysi
cohort
case
model
establish
valid
new
cohort
patient
differ
hospit
studi
hope
experi
outbreak
china
assist
rest
world
better
stratif
patient
achiev
better
outcom
patient
retrospect
observ
studi
perform
offici
design
treatment
center
confirm
patient
wuhan
center
outbreak
china
protocol
approv
local
institut
ethic
committe
approv
number
first
cohort
patient
admit
tongji
hospit
within
januari
februari
enrol
studi
model
develop
second
cohort
patient
admit
jinyintan
hospit
includ
previou
studi
reus
model
valid
patient
diagnos
posit
test
novel
coronaviru
nucleic
acid
accord
interim
guidanc
patient
discharg
hospit
die
includ
studi
six
patient
second
cohort
die
quickli
admiss
receiv
laboratori
test
exclud
patient
younger
year
age
also
exclud
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
clinic
data
includ
demograph
inform
chronic
comorbid
biomark
infect
laboratori
test
collect
local
onlin
medic
system
time
onset
symptom
hospit
admiss
also
record
sofa
calcul
within
admiss
patient
arteri
blood
ga
analysi
peripher
capillari
oxygen
satur
estim
arteri
oxygen
partial
pressur
record
fraction
inspir
oxygen
use
sofa
score
respiratori
system
calcul
accord
pf
ratio
patient
receiv
noninvas
invas
mechan
ventil
patient
close
follow
die
discharg
hospit
hospit
mortal
length
hospit
stay
also
record
data
fulli
anonym
data
clean
analys
follow
tripod
guidanc
develop
valid
report
multivari
predict
model
analys
perform
r
version
develop
model
built
use
data
tongji
hospit
perform
logist
regress
analysi
outcom
variabl
defin
mortal
variabl
select
priori
base
previou
clinicallyrel
studi
complet
across
site
clinic
knowledg
practic
measur
acut
medic
emerg
variabl
exclud
high
collinear
global
score
number
predictor
restrict
base
total
number
outcom
develop
dataset
analysi
conduct
follow
nine
variabl
age
hypertens
diabet
systol
blood
pressur
albumin
lactat
dehydrogenas
ldh
lymphocyt
count
platelet
count
organspecif
marker
alanin
transaminas
alt
blood
urea
nitrogen
bun
includ
origin
develop
model
collinear
global
marker
particularli
ldh
sofa
score
includ
reason
explain
result
ddimer
interleukin
il
cardiac
troponin
ctni
exclud
analysi
routin
test
cohort
ldh
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
select
gener
marker
cell
injuri
death
sinc
blood
ga
analysi
commonli
use
hospit
select
reflect
respiratori
function
model
continu
variabl
maxim
statist
power
albumin
select
marker
acut
phase
respons
instead
c
reactiv
protein
crp
crp
collinear
ldh
age
known
risk
factor
mortal
sever
respiratori
infect
includ
lymphocyt
count
platelet
count
report
previou
public
select
studi
lymphocyt
count
log
transform
due
extrem
valu
systol
blood
pressur
sbp
diabet
hypertens
select
base
previou
public
nine
select
variabl
input
multivari
model
backward
stepwis
select
perform
improv
goodnessoffit
assess
reduct
akaik
inform
criterion
aic
nomogram
select
final
model
use
graphic
represent
predict
model
produc
r
function
regplotthi
chosen
offer
maximum
use
predict
model
clinic
practic
without
need
internet
access
model
perform
assess
via
measur
discrimin
calibr
assess
discrimin
c
statist
use
calibr
patient
develop
databas
split
decil
order
probabl
death
decil
mean
predict
probabl
death
calcul
compar
mean
observ
probabl
death
calibr
plot
construct
includ
local
estim
scatterplot
smooth
loess
regress
line
intern
valid
assess
bootstrap
replic
entir
model
build
process
includ
backward
stepwis
select
potenti
predictor
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
calcul
optim
optim
adjust
discrimin
calibr
statist
final
develop
model
coeffici
adjust
optim
use
optim
adjust
calibr
slope
shrinkag
assess
extern
valid
final
optimismadjust
model
appli
independ
data
set
jinyintan
hospit
extern
valid
model
assess
use
c
statist
calibrationinthelarg
calibr
slope
calibr
plot
recalibr
conduct
updat
intercept
intercept
slope
develop
cohort
includ
patient
admit
tongji
hospit
data
complet
present
supplementari
tabl
death
median
age
patient
year
iqr
male
tabl
valid
cohort
includ
patient
younger
age
year
iqr
higher
percentag
male
development
cohort
p
median
iqr
time
onset
symptom
hospit
admiss
differ
development
valid
cohort
patient
hypertens
vs
heart
failur
vs
develop
valid
cohort
whilst
diabet
vs
chronic
obstruct
pulmonari
diseas
copd
vs
other
vs
show
statist
differ
sofa
score
statist
higher
develop
valid
cohort
vs
low
compar
common
critic
ill
tabl
show
nonsurvivor
significantli
older
survivor
year
iqr
vs
iqr
p
patient
hypertens
show
significantli
higher
mortal
rate
p
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
development
cohort
tongji
hospit
patient
complet
data
nine
variabl
final
multivari
model
includ
age
adjust
ci
ldh
adjust
ci
log
lymphocyt
count
adjust
ci
adjust
ci
tabl
final
model
show
excel
discrimin
c
statist
well
calibr
slope
calibrationinthelarg
shown
calibr
plot
tabl
figur
final
model
mortal
present
nomogram
exampl
use
nomogram
present
patient
age
ldh
lymphocyt
count
figur
interv
valid
run
use
bootstrap
resampl
show
small
amount
overfit
bootstrap
backward
stepwis
select
provid
shrinkag
factor
adjust
overfit
final
model
retain
high
discrimin
c
statist
calibrationinthelarg
tabl
shrinkag
factor
appli
coeffici
multivari
model
provid
optim
adjust
coeffici
tabl
extern
valid
requir
accuraci
predict
model
alway
high
valid
develop
cohort
use
gener
model
studi
appli
final
predict
model
optim
adjust
coeffici
valid
dataset
patient
valid
dataset
patient
die
patient
complet
data
four
variabl
final
development
model
age
lymphocyt
count
ldh
c
statist
discrimin
develop
model
independ
data
model
reason
calibr
slope
calibrationinthelarg
tabl
figur
suggest
miscalibr
model
independ
data
overestim
risk
mortal
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
lowrisk
individu
underestim
risk
highrisk
individu
recalibr
intercept
discrimin
model
expect
given
recalibr
influenc
rank
individu
accord
model
calibr
slope
calibrationinthelarg
calibr
plot
still
suggest
miscalibr
model
figur
intercept
slope
recalibr
calibr
slope
plot
demonstr
good
calibr
figur
routin
score
system
sofa
use
intens
care
unit
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
final
model
optim
use
clinician
give
predict
mortal
thu
inform
treatment
choic
guid
patient
famili
counsel
old
age
major
factor
mortal
infect
consist
current
data
china
less
children
year
old
increas
age
respect
howev
major
peopl
infect
year
old
approxim
total
case
therebi
make
difficult
stratifi
major
case
accord
age
patient
comorbid
includ
hypertens
diabet
significantli
contribut
model
although
mortal
rate
significantli
higher
patient
hypertens
patholog
featur
mainli
viral
pneumonia
alveolar
oedema
blockag
small
bronchi
compromis
ga
exchang
within
lung
therefor
drop
sever
pneumonia
develop
sinc
arteri
blood
ga
abg
analysi
invas
complex
process
requir
arteri
blood
take
use
abg
analyz
measur
much
use
continu
analysi
blood
oxygen
satur
patient
estim
arteri
oxygen
partial
pressur
moreov
mani
mobil
phone
brand
contain
builtin
sensor
measur
patient
cohort
mani
patient
blood
ga
data
therefor
use
variabl
model
although
accur
critic
ill
could
give
first
indic
compromis
lung
ga
exchang
earli
stage
would
verifi
abg
measur
upon
admiss
hospit
particularli
sepsi
cell
apoptosi
caus
prolong
infect
promot
viru
surviv
induc
immun
suppress
increas
mortal
patient
sepsi
studi
found
dramat
differ
lymphocyt
count
survivor
nonsurvivor
nonsurvivor
peripher
lymphocyt
count
low
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
admiss
indic
extens
lymphocyt
death
occur
follow
infect
ldh
releas
circul
cell
injuri
death
serv
index
extent
cellular
damag
viru
host
immun
respons
studi
sever
limit
stage
global
outbreak
publish
studi
develop
valid
predict
model
assess
probabl
mortal
hospit
patient
recent
report
propos
sofa
score
age
ddimer
import
prognost
marker
howev
cohort
sofa
score
low
although
statist
differ
survivor
nonsurvivor
differ
may
due
patient
treat
hospit
prior
transfer
previous
report
studi
addit
sofa
score
reli
blood
ga
analysi
easili
done
continu
clinic
underresourc
set
thu
make
difficult
clinician
use
readili
addit
sinc
ddimer
routin
request
mani
patient
cohort
test
perform
make
difficult
us
verifi
publish
result
organspecif
injuri
marker
includ
model
includ
ctni
due
miss
data
routin
measur
well
alt
bun
due
high
colinear
variabl
within
model
therefor
choic
potenti
prognost
factor
could
inform
systemat
review
exist
predict
model
similarli
publish
estim
discrimin
calibr
compar
studi
addit
event
rate
limit
especi
independ
dataset
least
event
would
prefer
multicent
studi
larger
cohort
model
develop
also
valid
would
add
power
reduc
bia
make
find
gener
applic
also
inher
bia
recruit
patient
jinyintan
hospit
first
offici
design
receiv
hospit
wuhan
case
start
outbreak
recruit
patient
mainli
selfreferr
refer
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
hospit
immedi
posit
diagnost
test
selfref
patient
like
sever
symptom
caus
seek
emerg
medic
help
likewis
hospit
like
test
patient
pronounc
symptom
thu
creat
inher
bia
patient
sampl
therefor
cohort
may
accur
repres
patient
mild
asymptomat
result
need
valid
patient
hospit
differ
sever
ill
conclus
tradit
earli
warn
score
organ
injuri
marker
help
predict
sever
mortal
patient
develop
valid
clinic
predict
model
use
readili
avail
clinic
marker
abl
accur
predict
mortal
peopl
model
therefor
use
current
pandem
region
identifi
patient
risk
sever
diseas
earli
enough
stage
initi
intens
support
treatment
guid
discuss
clinician
patient
famili
potenti
use
throughout
world
follow
addit
valid
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
relev
worldwid
dataset
recalibr
necessari
account
differ
risk
profil
patient
role
fund
sourc
sponsor
involv
studi
design
data
collect
data
analysi
data
interpret
write
report
correspond
author
full
access
data
final
respons
studi
dh
fund
outsid
scope
work
nihr
postdoctor
fellowship
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
figur
nomogram
final
develop
model
nomogram
present
distribut
continu
variabl
categor
variabl
rel
contribut
variabl
model
reflect
size
distribut
final
score
shown
develop
data
red
dot
repres
randomli
select
patient
develop
dataset
probabl
mortal
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
